Bausch + Lomb Corporation
NYSE: BLCO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Brenton L. Saunders
- Employees
- 13,500
- Headquarters
- Vaughan, Canada
- IPO year
- 2022
- Market cap
- $5.5B
- Website
- https://www.bausch.com
Loading BLCO…
Loading profile data…Frequently asked questions about BLCO
What does Bausch + Lomb Corporation (BLCO) do?
Bausch + Lomb Corporation is a leading global eye health company. Its operations are structured across three primary segments: Vision Care/Consumer Health, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health division offers a comprehensive portfolio of contact lenses, encompassing all wearing modalities from daily disposabl...
Where does BLCO trade?
Bausch + Lomb Corporation (BLCO) trades on the New York Stock Exchange.
What sector is BLCO in?
Bausch + Lomb Corporation (BLCO) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Bausch + Lomb Corporation?
Brenton L. Saunders is the chief executive officer of Bausch + Lomb Corporation (BLCO).
Where is Bausch + Lomb Corporation headquartered?
Bausch + Lomb Corporation is headquartered in Canada.
Does BLCO pay a dividend?
Bausch + Lomb Corporation (BLCO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BLCO go public?
Bausch + Lomb Corporation (BLCO) completed its initial public offering in 2022.